# PYXIS ONCOLOGY INC (PYXS)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/PYXS/

- Reporting holders: 80
- Reported value: $109.0M
- Shares held by institutions: 36,186,154 of 83,408,050 outstanding
- Held through calls: 1.6%
- Held through puts: 0.1%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GordonMD Global Investments LP](https://holderbook.com/funds/2039349-gordonmd-global-investments-lp/) | $30.2M | 10,024,909 | 14.6% | 3 |
| [Pfizer Inc](https://holderbook.com/funds/78003-pfizer-inc/) | $19.5M | 7,032,770 | 11.4% | 7 |
| [Laurion Capital Management LP](https://holderbook.com/funds/1390202-laurion-capital-management-lp/) | $14.8M | 4,900,888 | 0.4% | 19 |
| [Palo Alto Investors LP](https://holderbook.com/funds/1306923-palo-alto-investors-lp/) | $7.8M | 2,592,831 | 0.4% | 8 |
| [VANGUARD CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/2100119-vanguard-capital-management-llc/) | $6.2M | 2,075,997 | 0.0% | 2 |
| [Atle Fund Management AB](https://holderbook.com/funds/1381843-atle-fund-management-ab/) | $2.9M | 966,459 | 0.8% | 3 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $2.6M | 867,934 | 0.0% | 8 |
| [MARSHALL WACE, LLP](https://holderbook.com/funds/1318757-marshall-wace-llp/) | $2.5M | 830,544 | 0.0% | 3 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $2.3M | 772,232 | 0.0% | 17 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $1.8M | 591,849 | 0.0% | 19 |
| [Woodline Partners LP](https://holderbook.com/funds/1784547-woodline-partners-lp/) | $1.6M | 523,999 | 0.0% | 1 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $1.5M | 497,674 | 0.0% | 19 |
| [683 Capital Management, LLC](https://holderbook.com/funds/1404574-683-capital-management-llc/) | $1.4M | 459,367 | 0.1% | 8 |
| [JACOBS LEVY EQUITY MANAGEMENT, INC](https://holderbook.com/funds/884414-jacobs-levy-equity-management-inc/) | $1.3M | 428,606 | 0.0% | 2 |
| [DIADEMA PARTNERS LP](https://holderbook.com/funds/2026172-diadema-partners-lp/) | $1.2M | 0 | 0.1% | 1 |
| [JANE STREET GROUP, LLC](https://holderbook.com/funds/1595888-jane-street-group-llc/) | $1.1M | 290,090 | 0.0% | 5 |
| [Longaeva Partners L.P.](https://holderbook.com/funds/2054122-longaeva-partners-l-p/) | $1.1M | 353,582 | 0.0% | 4 |
| [Decheng Capital LLC](https://holderbook.com/funds/2010850-decheng-capital-llc/) | $983.7K | 326,810 | 0.1% | 11 |
| [VANGUARD FIDUCIARY TRUST CO](https://holderbook.com/funds/933478-vanguard-fiduciary-trust-co/) | $912.0K | 302,986 | 0.0% | 2 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $701.3K | 233,004 | 0.0% | 11 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $467.2K | 155,217 | 0.0% | 14 |
| [Bank of New York Mellon Corp](https://holderbook.com/funds/1390777-bank-of-new-york-mellon-corp/) | $403.3K | 133,996 | 0.0% | 14 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $380.0K | 126,793 | 0.0% | 2 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $373.3K | 94,634 | 0.0% | 4 |
| [NORTHERN TRUST CORP](https://holderbook.com/funds/73124-northern-trust-corp/) | $373.1K | 123,959 | 0.0% | 19 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 80 | $109.0M |
| Q1 2026 | 77 | $40.8M |
| Q4 2025 | 79 | $35.4M |
| Q3 2025 | 74 | $60.1M |
| Q2 2025 | 74 | $30.3M |
| Q1 2025 | 90 | $29.7M |
| Q4 2024 | 99 | $50.3M |
| Q3 2024 | 90 | $104.7M |
| Q2 2024 | 79 | $94.8M |
| Q1 2024 | 71 | $98.8M |
| Q4 2023 | 51 | $15.9M |
| Q3 2023 | 49 | $15.3M |